Ten-Year Outcomes of Intravitreal Bevacizumab for Myopic Choroidal Neovascularization: Analysis of Prognostic Factors

• Main Authors: Fabiana Mallone (Author), Rosalia Giustolisi (Author), Federica Franzone (Author), Marco Marenco (Author), Rocco Plateroti (Author), Marcella Nebbioso (Author), Alessandro Lambiase (Author), Magda Gharbiya (Author)
• Format: Book
• Published: MDPI AG, 2021-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The current standard treatment of myopic choroidal neovascularisation (mCNV) is intravitreal injection of VEGF antagonists. This study was proposed to assess efficacy and safety of intravitreal bevacizumab (IVB) for the treatment of mCNV across a 10-year follow-up. Thirty eyes of thirty patients wit...